🇺🇸 FDA
Patent

US 11717547

Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

granted A61KA61K35/763A61K9/0014

Quick answer

US patent 11717547 (Compositions and methods for the treatment of autosomal recessive congenital ichthyosis) held by Krystal Biotech, Inc. expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/763, A61K9/0014, A61P, A61P17/00